Revenues | |
Product sales | 1.07M |
License fees | 60K |
Commercial collaborations | |
Contracts and grants | |
Total revenues | 1.13M |
Cost of goods sold | |
Product | 1.21M |
Commercial collaborations | |
Contracts and grants | |
Warranty and inventory reserves | |
Total cost of goods sold | 1.21M |
Gross (loss) profit | -74K |
Operating expenses | |
Research and development | 1.08M |
Sales and marketing | 201K |
General and administrative | 1.91M |
Depreciation and amortization | 444K |
Loss on disposal of assets | |
Total operating expenses | 3.68M |
Loss from operations | -3.76M |
Other (expense) income | |
Interest expense | |
Interest income | |
Change in market value of warrants | |
Gain/(loss) on foreign exchange | |
Total other income, net | 12K |
Loss from continuing operations | |
Gain from discontinued operations | |
Net loss | |
Less: Net loss attributable to non-controlling interest | |
Net loss attributable to Altair Nanotechnologies Inc. | -3.74M |
Net loss attributable to Altair Nanotechnologies Inc. shareholders: | |
Loss from continuing operations | |
Gain from discontinued operations | |
Net loss | |
Earnings per share attributable to Altair Nanotechnologies Inc. shareholders: | |
Loss from continuing operations (in Dollars per share) | |
Loss per common share - basic and diluted (in Dollars per share) | -0.32 |
Weighted average shares - basic and diluted (in Shares) |